A genetically defined signature of responsiveness to erlotinib in early-stage pancreatic cancer patients: Results from the CONKO-005 trial

by K. Hoyer, R. Hablesreiter, Y. Inoue, K. Yoshida, F. Briest, F. Christen, N. Kakiuchi, T. Yoshizato, Y. Shiozawa, Y. Shiraishi, J.K. Striefler, S. Bischoff, P. Lohneis, H. Putter, O. Blau, U. Keilholz, L. Bullinger, U. Pelzer, M. Hummel, H. Riess, S. Ogawa, M. Sinn, F. Damm
Published 2021-04-01

Cluster‐randomized crossover trial of chlorhexidine–alcohol versus iodine–alcohol for prevention of surgical‐site infection (SKINFECT trial)

by A. Charehbili, M. B. G. Koek, J. C. A. deMol van Otterloo, M. W. G. A. Bronkhorst, P. van derZwaal, B. Thomassen, E. J. Waasdorp, J. A. Govaert, A. Bosman, J. van denBremer, A. J. Ploeg, H. Putter, A. P. Meijs, C. J. H. van deVelde, W. vanGijn, R. J. Swijnenburg
Published 2019-10-01